SINGAPORE — Twenty-four private healthcare institutions have been selected to administer the Government's stock of Sinovac Covid-19 vaccines, the Ministry of Health (MOH) said on Wednesday (June 16).

Fees range from S$10 to S$25 for a single dose.

Through a special route for as-yet-approved Covid-19 vaccines, the healthcare providers may draw upon MOH's existing stock to administer Sinovac's two-dose vaccine to Singaporeans, permanent residents and those holding long-term passes.

Applications by providers to administer the vaccine were reviewed based on their ability to do so safely, properly and efficiently, MOH said.

Other factors the ministry considered were the providers’ proposed vaccination administration fees, experience in vaccine administration and its compliance history at past licensing inspections.

This was done to ensure that services would be safe and affordable to members of public, it said.

"As these vaccines are being provided to (them) at no cost, individuals should take note that the providers should not charge them for the vaccine cost," MOH added.

The fees listed are also inclusive of consultation and the seven per cent Goods and Services Tax.

"There should not be any additional costs (beyond the vaccination administration fees) charged by these providers," MOH said.

For people who had been rejected from taking the approved Pfizer-BioNTech and Moderna vaccines under the national vaccination exercise, or people who were allergic to these vaccines, the Government will  reimburse them the fees if they decide to take the Sinovac vaccine.

Those interested in receiving the Sinovac vaccine may directly contact the providers listed in chart above from June 18 for more information.

The ministry also reiterated that Sinovac is not part of the voluntary national vaccine programme and therefore will not be covered under the Vaccine Injury Financial Assistance Programme. This is financial aid is for people who experience serious side effects that are assessed to be related to Covid-19 vaccines administered in Singapore.

Those who still wish to receive the Sinovac vaccine should discuss the risks and benefits with their doctors at their selected private healthcare institutions, MOH said. CNA

For more reports like this, visit cna.asia.